Meanings of the Colors of Cancer Bracelets

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight against many different cancers. Color makes all the difference when it comes to which cancer you are trying to bring awareness to or trying to raise money for; however, there are far more subtypes of cancer than there are shades of color that are easily distinguishable by the naked eye—therefore, in most cases, one color will represent more than one subtypes of cancer.

In fact, colored awareness bracelets don't automatically represent cancers only—they represent many different diseases and conditions to which people are trying to draw awareness.

That said, in general the following colors are associated with the following cancer types, and it should be noted that while some colors and associations make sense, others do not and aren't meant to.

Pink

Breast cancer. Breast cancer advocates absolutely own the color pink. This could not be mistaken for any other cancer.

Orange

Leukemia
Kidney cancer

Green

Non-Hodgkin's Lymphoma

Yellow

Liver cancer
Bladder cancer
Sarcomas

Black

Melanoma

Purple

Pancreatic cancer
Hodgkin's Lymphoma
Esophageal cancer
Thyroid cancer

Blue

Prostate cancer
Colorectal cancer

Grey

Brain cancer

Clear (or White or Pearl)

Lung cancer
Bone cancer

Teal

Gynecological cancers:

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap